- Login
- Register & Subscribe
- Language: EN FR DE
Switzerland
Cytos Biotechnology AG, the Swiss developer of therapeutic vaccines, is focusing its future development work on partnerships with Novartis and Pfizer to conserve cash ahead of the scheduled repayment of its convertible debt in February 2012.
Monday March 8 2010
Monday March 8 2010
Monday March 8 2010
Monday March 8 2010
Monday March 8 2010